NCT02807415View on ClinicalTrials.gov

ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

February 10, 2020

Conditions
Cystic Fibrosis
Interventions
DRUG

Lumacaftor plus Ivacaftor

Oral treatment with lumacaftor/ivacaftor tablets according to the prescribing information

Trial Locations (3)

30625

Hannover Medical School, Hanover

35385

Justus-Liebig-University, Giessen

69120

University of Heidelberg, Heidelberg

All Listed Sponsors
collaborator

Heidelberg University

OTHER

collaborator

University of Giessen

OTHER

lead

Hannover Medical School

OTHER

NCT02807415 - ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor | Biotech Hunter | Biotech Hunter